autologous IFN-gamma stimulated marrow-derived mesenchymal stromal cells (University of Wisconsin)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous IFN-gamma stimulated marrow-derived mesenchymal stromal cells (University of Wisconsin)
Drug Alias Nameautologous IFN-gamma stimulated MSCs (University of Wisconsin)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsXerostomia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin-Madison
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Wisconsin-Madison
Inactive CompaniesN/A
Active IndicationsXerostomia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A